Triple therapy prevention of Recurrent Intracerebral Disease Events Trial

Lead PI: Prof Craig Anderson & Prof Clara Chow

Status: Recruiting

No. of Patients Currently Recruited: 473                            No. of Patients Required: 4200

TRIDENT is an international, multi-centre, randomised control trial aiming to determine the effect of more intensive blood pressure control, utilising a low-dose combination of blood pressure medications, to prevent recurrent stroke in patients who have had an intracerebral haemorrhage (ICH).   

Trial URL: Identifier: NCT02699645

Related Posts